Clinical Trials Directory

Trials / Completed

CompletedNCT04315038

Metabolomics Profiling Research of Human Cerebrospinal Fluid in Aging Process

Metabolomics Profiling and Biomarker Research of Human Cerebrospinal Fluid in Aging Process and Age-related Neurodegenerative Diseases

Status
Completed
Phase
Study type
Observational
Enrollment
190 (actual)
Sponsor
Chang Gung Memorial Hospital · Academic / Other
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

Perform quantitative metabolomics on human cerebrospinal fluid (CSF) samples and establish the first human CSF Metabolome Database of aging process in Taiwan.

Detailed description

Metabolomics is new science based on metabolite profiles in biofluids and tissues, which under bioinformatics approaches and analyses could help to characterize metabolomic status of CSF in aging process. In this prospective study, the investigators plan to enroll 200 health volunteers and 40 neurodegenerative diseases patients with received operation under spinal anesthesia. Blood and CSF samples will be analyzed using hydrogen-1 nuclear magnetic resonance (1H-NMR) and lipid chromatography-mass spectrometry (LC-MS).

Conditions

Interventions

TypeNameDescription
PROCEDUREspinal anesthesiaPlan to enroll 200 health volunteers and 40 neurodegenerative diseases patients with received spinal anesthesia. Blood will be collected at time point of pre-anesthesia 10 minutes and CSF samples will be collected at time point during spinal anesthesia induction. Blood will be collected, drawn into EDTA-coated tube.

Timeline

Start date
2019-08-01
Primary completion
2021-07-31
Completion
2021-07-31
First posted
2020-03-19
Last updated
2022-01-31

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04315038. Inclusion in this directory is not an endorsement.